Cyprus vs Developing regions: Proportion of the target population who received the final dose of
Cyprus
89.0%
in 2024
Developing regions
26.0%
in 2024
Cyprus rank
11th
Developing regions rank
24th
Proportion of the target population who received the final dose of over time
- Cyprus
- Developing regions
How they compare
Cyprus currently reports 89.0% against 26.0% in Developing regions, a difference of 63.0%.
That makes Cyprus's figure about 3.4 times Developing regions's.
Across all 7 years both countries report, Cyprus has been ahead every year.
Cyprus ranks 11th and Developing regions ranks 24th of 107 countries.
Cyprus has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cyprus | Developing regions | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.7% | 9.0% | 52.7% | Cyprus |
| 2020s | 84.5% | 15.5% | 69.0% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Cyprus or Developing regions?
- Cyprus, at 89.0% against 26.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Cyprus and Developing regions?
- 63.0%, with Cyprus ahead.
- How many years of comparable data are there for Cyprus and Developing regions?
- 7 years are reported by both, from 2017 to 2024.
- How do Cyprus and Developing regions rank globally for proportion of the target population who received the final dose of?
- Cyprus ranks 11th and Developing regions ranks 24th of 107 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.